# Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

> **NCT07706829** · — · NOT_YET_RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease (PD)
- REM Sleep Behavior Disorder (iRBD)
- Neurogenic Orthostatic Hypotension
- Hyposmia

## Interventions

- **DEVICE:** Smartwatch and phone app

## Key facts

- **NCT ID:** NCT07706829
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706829, "Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07706829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*